Aberrant septin 9 DNA methylation in colorectal cancer is restricted to a single CpG island

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Wasserkort, Reinhold ^a,b   Kalmar, Alexandra ^c   Valcz, Gabor ^c   Spisak, Sandor ^c   Krispin, Manuel ^a,d   Toth, Kinga ^c   Tulassay, Zsolt ^c,e   Sledziewski, Andrew Z ^a   Molnar, Bela ^c,e  

^a EPIGENOMICS AG   (Germany)

^b Delta Vir GmbH   (Germany)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d Zymo Research Corporation   (United States)

^e INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Adenoma; Colorectal cancer; Direct bisulfite sequencing; DNA methylation; Epithelial cells; Immunohistochemistry; Septin 9; Stromal cells

Indexed keywords

SEPTIN; SEPTIN 9; UNCLASSIFIED DRUG;

ADENOMATOUS POLYP; ADULT; AGED; AMPLICON; ARTICLE; CANCER TISSUE; COLON ADENOMA; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; PROTEIN EXPRESSION; SEPTIN 9 GENE; STROMA CELL;

ADULT; AGED; COLORECTAL NEOPLASMS; CPG ISLANDS; DNA METHYLATION; FEMALE; GENE ORDER; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; SEPTINS; YOUNG ADULT;

EID: 84883274107     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-398     Document Type: Article

References (44)

1. Novak P, Jensen TJ, Garbe JC, Stampfer MR, Futscher BW. Stepwise DNA methylation changes are linked to escape from defined proliferation barriers and mammary epithelial cell immortalization. Cancer Res 2009, 69:5251-5258. 10.1158/0008-5472.CAN-08-4977, 2697259, 19509227.
2. Feinberg AP, Ohlsson R, Henikoff S. The epigenetic progenitor origin of human cancer. Nat Rev Genet 2006, 7:21-33. 10.1038/nrg1748, 16369569.
3. Baylin SB, Jones PA. A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer 2011, 11:726-734. 10.1038/nrc3130, 3307543, 21941284.
4. Osaka M, Rowley JD, Zeleznik-Le NJ. MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25). Proc Natl Acad Sci U S A 1999, 96:6428-6433. 10.1073/pnas.96.11.6428, 26898, 10339604.
5. Russell SE, McIlhatton MA, Burrows JF, Donaghy PG, Chanduloy S, Petty EM, Kalikin LM, Church SW, McIlroy S, Harkin DP, Keilty GW, Cranston AN, Weissenbach J, Hickey I, Johnston PG. Isolation and mapping of a human septin gene to a region on chromosome 17q commonly deleted in sporadic epithelial ovarian tumors. Cancer Res 2000, 60:4729-4734.
6. Montagna C, Lyu MS, Hunter K, Lukes L, Lowther W, Reppert T, Hissong B, Weaver Z, Ried T. The Septin 9 (MSF) gene is amplified and overexpressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines. Cancer Res 2003, 63:2179-2187.
7. Scott M, Hyland PL, McGregor G, Hillan KJ, Russell SE, Hall PA. Multimodality expression profiling shows SEPT9 to be overexpressed in a wide range of human tumours. Oncogene 2005, 24:4688-4700. 10.1038/sj.onc.1208574, 15782116.
8. Estey MP, Kim MS, Trimble WS. Septins. Curr Biol 2011, 21:R384-R387. 10.1016/j.cub.2011.03.067, 21601794.
9. Sandrock K, Bartsch I, Bläser S, Busse A, Busse E, Zieger B. Characterization of human septin interactions. Biol Chem 2011, 392:751-761.
10. McIlhatton MA, Burrows JF, Donaghy PG, Chanduloy S, Johnston PG, Russell SE. Genomic organization, complex splicing pattern and expression of a human septin gene on chromosome 17q25.3. Oncogene 2001, 20:5930-5939. 10.1038/sj.onc.1204752, 11593400.
11. Peterson EA, Petty EM. Conquering the complex world of human septins: implications for health and disease. Clin Genet 2010, 77:511-524. 10.1111/j.1399-0004.2010.01392.x, 20236126.
12. Scott M, McCluggage WG, Hillan KJ, Hall PA, Russell SE. Altered patterns of transcription of the septin gene, SEPT9, in ovarian tumorigenesis. Int J Cancer 2006, 118:1325-1329. 10.1002/ijc.21486, 16161048.
13. Gonzalez ME, Peterson EA, Privette LM, Loffreda-Wren JL, Kalikin LM, Petty EM. High SEPT9_v1 expression in human breast cancer cells is associated with oncogenic phenotypes. Cancer Res 2007, 67:8554-8564. 10.1158/0008-5472.CAN-07-1474, 17875694.
14. McDade SS, Hall PA, Russell SE. Translational control of SEPT9 isoforms is perturbed in disease. Hum Mol Genet 2007, 16:742-752. 10.1093/hmg/ddm003, 17468182.
15. Connolly D, Abdesselam I, Verdier-Pinard P, Montagna C. Septin roles in tumorigenesis. Biol Chem 2011, 392:725-738.
16. Connolly D, Yang Z, Castaldi M, Simmons N, Oktay MH, Coniglio S, Fazzari MJ, Verdier-Pinard P, Montagna C. Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression. Breast Cancer Res 2011, 13:R76. 10.1186/bcr2924, 3236340, 21831286.
17. Lofton-Day C, Model F, Devos T, Tetzner R, Distler J, Schuster M, Song X, Lesche R, Liebenberg V, Ebert M, Molnar B, Grützmann R, Pilarsky C, Sledziewski A. DNA methylation biomarkers for bloodbased colorectal cancer screening. Clin Chem 2008, 54:414-423. 10.1373/clinchem.2007.095992, 18089654.
18. Grützmann R, Molnar B, Pilarsky C, Habermann JK, Schlag PM, Saeger HD, Miehlke S, Stolz T, Model F, Roblick UJ, Bruch HP, Koch R, Liebenberg V, Devos T, Song X, Day RH, Sledziewski AZ, Lofton-Day C. Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS One 2008, 3:e3759. 10.1371/journal.pone.0003759, 2582436, 19018278.
19. DeVos T, Tetzner R, Model F, Weiss G, Schuster M, Distler J, Steiger KV, Grützmann R, Pilarsky C, Habermann JK, Fleshner PR, Oubre BM, Day R, Sledziewski AZ, Lofton-Day C. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem 2009, 55:1337-1346. 10.1373/clinchem.2008.115808, 19406918.
20. Payne SR. From discovery to the clinic: the novel DNA methylation biomarker (m)SEPT9 for the detection of colorectal cancer in blood. Epigenomics 2010, 2:575-585. 10.2217/epi.10.35, 22121975.
21. Epi proColon website http://www.epigenomics.com/en/products-services/epi-procolon.html.
22. Mouliere F, Robert B, Arnau Peyrotte E, Del Rio M, Ychou M, Molina F, Gongora C, Thierry AR. High fragmentation characterizes tumour-derived circulating DNA. PLoS One 2011, 6:e23418. 10.1371/journal.pone.0023418, 3167805, 21909401.
23. Dietrich D, Lesche R, Tetzner R, Krispin M, Dietrich J, Haedicke W, Schuster M, Kristiansen G. Analysis of DNA methylation of multiple genes in microdissected cells from formalin-fixed and paraffin-embedded tissues. J Histochem Cytochem 2009, 57:477-489. 10.1369/jhc.2009.953026, 2674771, 19153192.
24. Eckhardt F, Lewin J, Cortese R, Rakyan VK, Attwood J, Burger M, Burton J, Cox TV, Davies R, Down TA, Haefliger C, Horton R, Howe K, Jackson DK, Kunde J, Koenig C, Liddle J, Niblett D, Otto T, Pettett R, Seemann S, Thompson C, West T, Rogers J, Olek A, Berlin K, Beck S. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet 2006, 38:1378-1385. 10.1038/ng1909, 3082778, 17072317.
25. Lewin J, Schmitt AO, Adorján P, Hildmann T, Piepenbrock C. Quantitative DNA methylation analysis based on four-dye trace data from direct sequencing of PCR amplificates. Bioinformatics 2004, 20:3005-3012. 10.1093/bioinformatics/bth346, 15247106.
26. Illingworth R, Kerr A, Desousa D, Jørgensen H, Ellis P, Stalker J, Jackson D, Clee C, Plumb R, Rogers J, Humphray S, Cox T, Langford C, Bird A. A novel CpG island set identifies tissue-specific methylation at developmental gene loci. PLoS Biol 2008, 6:e22. 10.1371/journal.pbio.0060022, 2214817, 18232738.
27. Tóth K, Galamb O, Spisák S, Wichmann B, Sipos F, Valcz G, Leiszter K, Molnár B, Tulassay Z. The influence of methylated septin 9 gene on RNA and protein level in colorectal cancer. Pathol Oncol Res 2011, 17:503-509. 10.1007/s12253-010-9338-7, 21267688.
28. Dakubo GD, Jakupciak JP, Birch-Machin MA, Parr RL. Clinical implications and utility of field cancerization. Cancer Cell Int 2007, 7:2. 10.1186/1475-2867-7-2, 1838897, 17362521.
29. Ushijima T. Epigenetic field for cancerization. J Biochem Mol Biol 2007, 40:142-150. 10.5483/BMBRep.2007.40.2.142, 17394762.
30. Peddareddigari VG, Wang D, Dubois RN. The tumor microenvironment in colorectal carcinogenesis. Cancer Microenviron 2010, 3:149-166. 10.1007/s12307-010-0038-3, 2990487, 21209781.
31. Ishiguro K, Yoshida T, Yagishita H, Numata Y, Okayasu T. Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas. Gut 2006, 55:695-702. 10.1136/gut.2005.079459, 1856111, 16354798.
32. Sheehan KM, Gulmann C, Eichler GS, Weinstein JN, Barrett HL, Kay EW, Conroy RM, Liotta LA, Petricoin EF. Signal pathway profiling of epithelial and stromal compartments of colonic carcinoma reveals epithelial-mesenchymal transition. Oncogene 2008, 27:323-331. 10.1038/sj.onc.1210647, 17621268.
33. Moncada-Pazos A, Obaya AJ, Fraga MF, Viloria CG, Capellá G, Gausachs M, Esteller M, López-Otín C, Cal S. The ADAMTS12 metalloprotease gene is epigenetically silenced in tumor cells and transcriptionally activated in the stroma during progression of colon cancer. J Cell Sci 2009, 122:2906-2913. 10.1242/jcs.050468, 19638407.
34. Bosman FT, de Bruïne A, Flohil C, van der Wurff A, ten Kate J, Dinjens WW. Epithelial-stromal interactions in colon cancer. Int J Dev Biol 1993, 37:203-211.
35. Hanson JA, Gillespie JW, Grover A, Tangrea MA, Chuaqui RF, Emmert-Buck MR, Tangrea JA, Libutti SK, Linehan WM, Woodson KG. Gene promoter methylation in prostate tumor-associated stromal cells. J Natl Cancer Inst 2006, 98:255-261. 10.1093/jnci/djj051, 16478744.
36. Shankar J, Messenberg A, Chan J, Underhill TM, Foster LJ, Nabi IR. Pseudopodial actin dynamics control epithelial-mesenchymal transition in metastatic cancer cells. Cancer Res 2010, 70:3780-3790. 10.1158/0008-5472.CAN-09-4439, 20388789.
37. Deaton AM, Bird A. CpG islands and the regulation of transcription. Genes Dev 2011, 25:1010-1022. 10.1101/gad.2037511, 3093116, 21576262.
38. Burrows JF, Chanduloy S, McIlhatton MA, Nagar H, Yeates K, Donaghy P, Price J, Godwin AK, Johnston PG, Russell SE. Altered expression of the septin gene, SEPT9, in ovarian neoplasia. J Pathol 2003, 201:581-588. 10.1002/path.1484, 14648661.
39. Bennett KL, Karpenko M, Lin MT, Claus R, Arab K, Dyckhoff G, Plinkert P, Herpel E, Smiraglia D, Plass C. Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma. Cancer Res 2008, 68:4494-4499. 10.1158/0008-5472.CAN-07-6509, 18559491.
40. Hackenberg M, Barturen G, Oliver JL. NGSmethDB: a database for next-generation sequencing single-cytosine-resolution DNA methylation data. Nucleic Acids Res 2011, 39(Database issue):D75-D79. 3013793, 20965971.
41. Wallace JA, Felsenfeld G. We gather together: insulators and genome organization. Curr Opin Genet Dev 2007, 17:400-407. 10.1016/j.gde.2007.08.005, 2215060, 17913488.
42. Burgess-Beusse B, Farrell C, Gaszner M, Litt M, Mutskov V, Recillas-Targa F, Simpson M, West A, Felsenfeld G. The insulation of genes from external enhancers and silencing chromatin. Proc Natl Acad Sci U S A 2002, 99(Suppl 4):16433-16437. 139905, 12154228.
43. Naumann A, Hochstein N, Weber S, Fanning E, Doerfler W. A distinct DNA-methylation boundary in the 5′- upstream sequence of the FMR1 promoter binds nuclear proteins and is lost in fragile X syndrome. Am J Hum Genet 2009, 85:606-616. 10.1016/j.ajhg.2009.09.018, 2775827, 19853235.
44. Hansen KD, Timp W, Bravo HC, Sabunciyan S, Langmead B, McDonald OG, Wen B, Wu H, Liu Y, Diep D, Briem E, Zhang K, Irizarry RA, Feinberg AP. Increased methylation variation in epigenetic domains across cancer types. Nat Genet 2011, 43:768-775. 10.1038/ng.865, 3145050, 21706001.